275 related articles for article (PubMed ID: 10805977)
21. Computerized Cytomorphometric and Cytomorphological Analysis of Canine Transmissible Venereal Tumours.
Setthawongsin C; Tangkawattana S; Rungsipipat A; Techangamsuwan S
J Comp Pathol; 2018 Aug; 163():18-22. PubMed ID: 30213369
[TBL] [Abstract][Full Text] [Related]
22. Cell cycle kinetics, apoptosis rates and gene expressions of MDR-1, TP53, BCL-2 and BAX in transmissible venereal tumour cells and their association with therapy response.
Flórez MM; Fêo HB; da Silva GN; Yamatogi RS; Aguiar AJ; Araújo JP; Rocha NS
Vet Comp Oncol; 2017 Sep; 15(3):793-807. PubMed ID: 26879698
[TBL] [Abstract][Full Text] [Related]
23. Transient downregulation of monocyte-derived dendritic-cell differentiation, function, and survival during tumoral progression and regression in an in vivo canine model of transmissible venereal tumor.
Liu CC; Wang YS; Lin CY; Chuang TF; Liao KW; Chi KH; Chen MF; Chiang HC; Chu RM
Cancer Immunol Immunother; 2008 Apr; 57(4):479-91. PubMed ID: 17710396
[TBL] [Abstract][Full Text] [Related]
24. Canine transmissible venereal tumor and seminoma: a cytohistopathology and chemotherapy study of tumors in the growth phase and during regression after chemotherapy.
Javanbakht J; Pedram B; Taheriyan MR; Khadivar F; Hosseini SH; Abdi FS; Hosseini E; Moloudizargari M; Aghajanshakeri SH; Javaherypour S; Shafiee R; Emrani Bidi R
Tumour Biol; 2014 Jun; 35(6):5493-500. PubMed ID: 24557542
[TBL] [Abstract][Full Text] [Related]
25. Transmission of canine transmissible venereal tumour between two dogs in the UK.
Hayes AM; Schiavo L; Constantino-Casas F; Desmas I; Dobson J; Draper A; Elliot J; Genain MA; Wang J; Murchison EP
J Small Anim Pract; 2023 Sep; 64(9):590-594. PubMed ID: 36990106
[TBL] [Abstract][Full Text] [Related]
26. Primary transmissible venereal tumour in the nasal cavity of a dog.
Ginel PJ; Molleda JM; Novales M; Martín E; Margarito JM; López R
Vet Rec; 1995 Mar; 136(9):222-3. PubMed ID: 7771073
[No Abstract] [Full Text] [Related]
27. Detection of the tumour suppressor gene TP53 and expression of p53, Bcl-2 and p63 proteins in canine transmissible venereal tumour.
Stockmann D; Ferrari HF; Andrade AL; Cardoso TC; Luvizotto MC
Vet Comp Oncol; 2011 Dec; 9(4):251-9. PubMed ID: 22077405
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical study of the local inflammatory infiltrate in spontaneous canine transmissible venereal tumour at different stages of growth.
Pérez J; Day MJ; Mozos E
Vet Immunol Immunopathol; 1998 Jul; 64(2):133-47. PubMed ID: 9661263
[TBL] [Abstract][Full Text] [Related]
29. Single-drug chemotherapy of canine transmissible venereal tumor with cyclophosphamide, methotrexate, or vincristine.
Amber EI; Henderson RA
J Vet Intern Med; 1992; 6(5):300. PubMed ID: 1432905
[No Abstract] [Full Text] [Related]
30. Proliferation characteristics of canine transmissible venereal tumor.
Chu RM; Lin CY; Liu CC; Yang SY; Hsiao YW; Hung SW; Pao HN; Liao KW
Anticancer Res; 2001; 21(6A):4017-24. PubMed ID: 11911286
[TBL] [Abstract][Full Text] [Related]
31. The role of the multi-drug resistance 1, p53, b cell lymphoma 2, and bcl 2-associated X genes in the biologic behavior and chemotherapeutic resistance of canine transmissible venereal tumors.
Alzate JM; Montoya-Florez LM; Pérez JE; Rocha NS; Pedraza-Ordonez FJ
Vet Clin Pathol; 2019 Dec; 48(4):730-739. PubMed ID: 31777108
[TBL] [Abstract][Full Text] [Related]
32. Vincristine for treatment of transmissible venereal tumor in the dog--.
Calvert CA; Leifer CE; MacEwen EG
J Am Vet Med Assoc; 1982 Jul; 181(2):163-4. PubMed ID: 6749780
[No Abstract] [Full Text] [Related]
33. Canine transmissible venereal tumour: cytogenetic origin, immunophenotype, and immunobiology. A review.
Mukaratirwa S; Gruys E
Vet Q; 2003 Sep; 25(3):101-11. PubMed ID: 14535580
[TBL] [Abstract][Full Text] [Related]
34. A 125IUdR technique for measuring the cell loss from subcutaneously growing canine transmissible venereal tumours.
Holmes JM
Res Vet Sci; 1981 Nov; 31(3):306-11. PubMed ID: 7342225
[TBL] [Abstract][Full Text] [Related]
35. Effects of vincristine treatment on semen quality in a dog with a transmissible venereal tumour.
Gobello C; Corrada Y
J Small Anim Pract; 2002 Sep; 43(9):416-7. PubMed ID: 12238508
[TBL] [Abstract][Full Text] [Related]
36. Risk factors and characteristics of canine transmissible venereal tumours in Grenada, West Indies.
Kabuusu RM; Stroup DF; Fernandez C
Vet Comp Oncol; 2010 Mar; 8(1):50-5. PubMed ID: 20230581
[TBL] [Abstract][Full Text] [Related]
37. Ocular manifestations of canine transmissible venereal tumour: a retrospective study of 25 cases in Greece.
Komnenou AT; Thomas AL; Kyriazis AP; Poutahidis T; Papazoglou LG
Vet Rec; 2015 May; 176(20):523. PubMed ID: 25888603
[TBL] [Abstract][Full Text] [Related]
38. Follow-up on chemotherapy of venereal tumors.
Brown NO; MacEwen EG; Clavert C
J Am Vet Med Assoc; 1980 Oct; 177(8):676. PubMed ID: 7440361
[No Abstract] [Full Text] [Related]
39. Effects of immunotherapy of IL-6 and IL-15 plasmids on transmissible venereal tumor in beagles.
Chou PC; Chuang TF; Jan TR; Gion HC; Huang YC; Lei HJ; Chen WY; Chu RM
Vet Immunol Immunopathol; 2009 Jul; 130(1-2):25-34. PubMed ID: 19200609
[TBL] [Abstract][Full Text] [Related]
40. Theriogenology question of the month. Transmissible venereal tumor (TVT).
Hasler AH; Weber WT
J Am Vet Med Assoc; 2000 May; 216(10):1557-9. PubMed ID: 10825939
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
